Blog
- Foundation Strategy
Embracing an Ecosystem Approach for Philanthropy
Funders are shifting from being at the center of social change efforts to working in close partnership with the…
- Corporate/CSR
Flying through Interference
We believe that corporate changemakers need tools to properly diagnose interference and build enabling conditions for social impact strategies…
New Corporate Innovation Models for Fighting NCDs
January 12, 2015Historically, non-communicable diseases (NCDs) have not enjoyed a high profile in global health circles and popular media alongside their communicable brethren…
Sustaining Rural Water Supply Using the Principles of Collective Impact
November 3, 2014Imagine for a moment you live in a rural village in sub-Saharan Africa, where access to clean water is a remote possibility. Imagine the sense of promise and o…
Adapting to Global Health Crises: Lessons from the HIV Response in Botswana
October 2, 2014Several threads in the news lately connect to how health systems pivot from crisis mode to a sustained response. The countries affected by the Ebola epidemic a…
USAID and INGOs – Traveling a New Path Together
March 17, 2014The landscape of international development, and the architecture of aid that has traditionally underpinned it, have shifted significantly over the last decade.…
Shaping Global Partnerships for a Post-2015 World
February 18, 2014We have made significant progress against the MDG (Millennium Development Goals) targets, but as the 2015 deadline is fast approaching, large gaps remain to be…
What Is the Social Value of Pharmaceuticals?
February 13, 2014What’s shared value’s place in big Pharma? Earlier this week I had the opportunity to discuss this question in a live online chat with Guardian Sustainable Bus…
Data on Global Cancer Rates, Visualized
February 11, 2014The announcement that CVS will no longer sell tobacco products in its U.S. stores is welcome news to many public health practitioners and advocates. Lung cance…
Why are Drugs so Expensive?
January 9, 2014Why drugs are so expensive: It's the science, stupidIn a new blog series from Scientific American discussing the challenges of drug discovery, chemist Ashutosh…
5 Notes on the Future of Next Generation Evaluation
January 2, 2014FSG’s Next Generation Evaluation Learning Brief was aimed at starting a conversation about how evaluation should evolve and grow to respond to social sector in…
Our Latest Research: Ahead of the Curve
December 11, 2013Over the last 70 years, International NGOs have become key development actors in global relief and development. The question for the next 20 years is whether t…